Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Hudson |
RCV001090107 | SCV001245571 | uncertain significance | Early-onset dementia of unclear type | 2019-10-28 | criteria provided, single submitter | research | |
Invitae | RCV002554805 | SCV003516518 | uncertain significance | Frontotemporal dementia | 2022-10-17 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MAPT protein function. ClinVar contains an entry for this variant (Variation ID: 870547). This missense change has been observed in individual(s) with dementia (PMID: 31836585). This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 392 of the MAPT protein (p.Ile392Val). |